FIGO Good Practice Recommendations on the use of progesterone in the management of recurrent first-trimester miscarriage

被引：4

作者：

Shehata, Hassan ^{[1
,2
,6
]}

Elfituri, Abdullatif ^{[2
]}

Doumouchtsis, Stergios K. ^{[2
]}

Zini, Mudiaga Eseajeberuo ^{[2
]}

Ali, Amanda ^{[3
]}

Jan, Haider ^{[2
]}

Ganapathy, Ramesh ^{[2
]}

Divakar, Hema ^{[4
]}

Hod, Moshe ^{[5
]}

机构：

[1] Southwest London & Surrey Heartlands Maternal Med, London, England

[2] Epsom & St Helier Univ Hosp NHS Trust, Epsom, England

[3] Kingston Hosp Fdn NHS Trust, Kingston, England

[4] Divakars Special Hosp, Bengaluru, India

[5] Mor Comprehens Womens Hlth Care Ctr, Tel Aviv, Israel

[6] Epsom & St Helier Univ Hosp NHS Trust, Southwest London & Surrey Heartlands Maternal Med, Epsom KT18 7EG, England

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS | 2023年 / 161卷

关键词：

LUTEAL-PHASE SUPPORT; 17-ALPHA-HYDROXY-PROGESTERONE CAPROATE; 17-ALPHA-HYDROXYPROGESTERONE CAPROATE; VAGINAL PROGESTERONE; THREATENED-ABORTION; PRETERM BIRTH; PREGNANCY; WOMEN; DYDROGESTERONE; PREVENTION;

D O I：

10.1002/ijgo.14717

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

[No abstract available]

引用

页码：3 / 16

页数：14

共 48 条

[1] The effect of early administration of rectal progesterone in IVF/ICSI twin pregnancies on the preterm birth rate: a randomized trial
Aboulghar, Mona Mohamed
El-Faissal, Yahia
Kamel, Ahmed
Mansour, Ragaa
Serour, Gamal
Aboulghar, Mohamed
Islam, Yomna
[J]. BMC PREGNANCY AND CHILDBIRTH, 2020, 20 (01)
[2] A randomized comparison of the efficacy, side effects and patient convenience between vaginal and rectal administration of CyclogestA® when used for luteal phase support in ICSI treatment
Aghsa, Malek-Mansour
Rahmanpour, Haleh
Bagheri, Maryam
Davari-Tanha, Fatemeh
Nasr, Reza
[J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2012, 286 (04) : 1049 - 1054
[3] Evaluation and treatment of recurrent pregnancy loss: a committee opinion
[J]. FERTILITY AND STERILITY, 2012, 98 (05) : 1103 - 1111
[4] RETRACTION: Peri-conceptional progesterone treatment in women with unexplained recurrent miscarriage: a randomized double-blind placebo-controlled trial (Retraction of Vol 31, Pg 388, 2018)
Ismail, Alaa M.
Abbas, Ahmed M.
Ali, Mohammed K.
Amin, Ahmed F.
[J]. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2020, 33 (06) : 1073 - 1073
[5] Progesterone profiles in luteal-phase defects associated with recurrent spontaneous abortions
Babalioglu, R
Varol, FG
Ilhan, R
Yalcin, O
Cizmecioglu, F
[J]. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1996, 13 (04) : 306 - 309
[6] Beigi A, 2016, INT J FERTIL STERIL, V10, P162
[7] Progesterone and preterm birth prevention: translating clinical trials data into clinical practice
Berghella, Vincenzo
[J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2012, 206 (05) : 376 - 386
[8] A systematic review of dydrogesterone for the treatment of threatened miscarriage
Carp, Howard
[J]. GYNECOLOGICAL ENDOCRINOLOGY, 2012, 28 (12) : 983 - 990
[9] Luteal phase support for frozen embryo transfer cycles: intramuscular or vaginal progesterone?
Casper, Robert F.
[J]. FERTILITY AND STERILITY, 2014, 101 (03) : 627 - 628
[10] Plasma concentrations of progesterone are higher in the uterine artery than in the radial artery after vaginal administration of micronized progesterone in an oil-based solution to postmenopausal women
Cicinelli, E
Cignarelli, M
Sabatelli, S
Romano, F
Schonauer, LM
Padovano, R
Einer-Jensen, N
[J]. FERTILITY AND STERILITY, 1998, 69 (03) : 471 - 473

← 1 2 3 4 5 →